Slide 1Cardiovascular Risk and dyslipidemia Dr Stéphane De Wit St Pierre Hospital - Brussels Slide 2 2 Cardiac Risk Factors What are cardiac risk factors?What are cardiac…

Slide 1Management of ARV 6th Advanced HIV Course, Montpellier, September 3-5, 2008 Jürgen Rockstroh, Department of Medicine I, University of Bonn, Germany Slide 2 Natural…

Slide 100002-E-1 – 1 December 2003 Anti-HIV drugs 2010-2011 Andrea De Luca, M.D. Institute of Clinical Infectious Diseases. Catholic University, Rome 2nd Division of Infectious…

Page 1 CR EACS Cologne 11-14 Novembre 2009 Page 2 LBPE9.7/8 - Prevalence of proximal renal tubular dysfunction (PRTD) and associated factors in HIV-infected patients, ANRS…

1. Can we cure HIV/AIDS?: A 2014 progress report Zeena Nackerdien 2. What constitutes a cure?(1) Eradication cure: no HIV, effective immune response, no HAART needed Functional…

Slide 1 Future HCV Treatment Paradigms Mark Sulkowski, MD Professor of Medicine Medical Director, Viral Hepatitis Center Divisions of Infectious Diseases and Gastroenterology/…

CR EACS Cologne 11-14 Novembre 2009 LBPE9.7/8 - Prevalence of proximal renal tubular dysfunction (PRTD) and associated factors in HIV-infected patients, ANRS CO3 Aquitaine…

Bone Turnover Suppression Based on an ASBMR/ECTS Clincal Debate âToo Much Suppression of Turnover Is Bad for Boneâ Co-Chairs: Socrates Papapoulos, Douglas C. Bauer Debaters:…

Supported by an unrestricted educational grant from July 11-16, 2004, Bangkok, Thailand TREATMENT HIGHLIGHTS OF THE Selected and summarized by Douglas J. Ward, MD, FACP Dupont…

Care of the Treatment-naive Patient With HCV/HIV Coinfection Care of the Treatment-naive Patient With HCV/HIV Coinfection Case 47-Year-Old Man With Asymptomatic HIV Infection…